丁香园 / DXY

DXY is one of the earliest professional internet-healthcare communities in No.206 检索、送药、看病：互联网医疗这些年 | 中国互联网故事22. The episode traces it to 李天天, who built a medical-literature search site after discovering PubMed while working on academic writing, then named it after Harbin’s lilac flower.

The source treats DXY as a case where professional user pain preceded the business model. Its early community and literature-search use later expanded into doctor recruiting through Dingxiang Talent, clinical drug reference through DXY’s medication tools, and public-facing health content through 丁香医生.

Key Points

• DXY began as a tool and community for doctors and medical students rather than as a consumer healthcare marketplace.
• The episode sees its origin as an example of Medical Literature Search creating a high-trust professional entry point.
• Tencent’s 2014 investment and later financing rounds mark the point where the professional community became a broader healthcare company.
• DXY’s later public-health role becomes visible through 丁香医生, medication guidance, epidemic information, and the Quanjian investigation article discussed under Medical Platform Trust Crisis.

Connections

• 李天天 — founder whose literature-search need led to the original site.
• PubMed and Medical Literature Search — the information-access context behind the community.
• 丁香医生 — public-facing health-content and medication-safety branch.
• Internet Healthcare and Medical Platform Trust Crisis — broader industry frames reinforced by DXY’s professional credibility.